Why Neurocrine is charging twice as much for its new drug as it said it would
May 02, 2017 at 07:45 AM EDT
Patients on the recommended dose will pay double — about $5,300 more a month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.